Skip to main content
OpenTrials

Clinical trial condition

Dermatitis, Atopic

Explore clinical trials studying Dermatitis, Atopic. Study availability and eligibility vary by location and protocol.

1,194 public trials 150 recruiting studies
Refine in advanced search Browse all conditions

Dermatitis, Atopic trial results

Completed

A Long-term Study of Baricitinib (LY3009104) With Topical Corticosteroids in Adults With Moderate to Severe Atopic Dermatitis That Are Not Controlled With Cyclosporine or for Those Who Cannot Take Oral Cyclosporine Because it is Not Medically Advisable

NCT03428100

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Universitätsklinikum Graz Graz, Styria, Austria
  • Universitätsklinik Innsbruck Innsbruck, Tyrol, Austria
  • KA Rudolfstiftung Vienna, Austria
  • AKH Vienna, Austria
View all 103 locations
View Trial Details
Completed

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

NCT03568331

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Vanda Investigational Site Birmingham, Alabama, United States
  • Vanda Investigational Site Birmingham, Alabama, United States
  • Vanda Investigational Site Tempe, Arizona, United States
  • Vanda Investigational Site Encino, California, United States
View all 70 locations
View Trial Details
Completed

Skin Pathology Assessment With Optical Technologies

NCT04295824

Conditions
Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Sheffield Dermatology Research, University of Sheffield Medical School, The Royal Hallamshire Hospital Sheffield, South Yorkshire, United Kingdom
View Trial Details
Completed

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT05158023

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • ASLAN Investigative Site Birmingham, Alabama, United States
  • ASLAN Investigative Site Birmingham, Alabama, United States
  • ASLAN Investigative Site Little Rock, Arkansas, United States
  • Tooraj Raoof, MD Encino, California, United States
View all 83 locations
View Trial Details
Completed

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

NCT03703102

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Kyowa Investigational Site US-19 Huntington Beach, California, United States
  • Kyowa Investigational Site US-17 Irvine, California, United States
  • Kyowa Investigational Site US-09 Los Angeles, California, United States
  • Kyowa Investigational Site US-05 Santa Ana, California, United States
View all 58 locations
View Trial Details
Completed

Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children

NCT06361992

Conditions
Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis Eczema, +12 more
Locations
  • University of Niš Faculty of Medicine, Department of Dermatology and Venereology, University Clinical Center of Niš Niš, Nišava, Serbia
  • City Institute for Skin and Venereal Diseases Belgrade Belgrade, Serbia
  • University of Belgrade Faculty of Medicine, University Clinical Center of Serbia Belgrade, Serbia
View Trial Details

Related conditions